TNFA
TNF Pharmaceuticals, Inc. Common Stock
TNFA
TNFA
24 hedge funds and large institutions have $65.5K invested in TNF Pharmaceuticals, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+9
Holders Change %
+60%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$11.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.99K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$6.21K |
| 4 |
Goldman Sachs
New York
|
+$5.58K |
| 5 |
Jane Street
New York
|
+$4.33K |
